Definitive Contract FA442720C0012
Award Date
1/1/20
Potential Completion Date
3/31/25
Potential Value
$643K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Air Mobility Command
Awardee
Genomic Health, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Travis AFB, Fairfield, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...
This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
This federal contract award is for ONCOTYPE TESTING services provided by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The $120,889 Firm Fixed Price contract was awarded by the Defense Health Agency, a component of the Department of Defense, on October 28, 2018. The contract has an ultimate completion date of October 28, 2019 and is a BPA Call, which allows the agency to order services on an as-needed basis. Genomic Health is a leading provider of genomic-based cancer testing...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of diagnostic testing supplies for cancer treatment. The potential value of the contract is $150,000.00, with a completion date of September 7, 2022. The contract was not set aside for any specific business type. Genomic Health has a history of providing cancer testing services, including its Oncotype DX portfolio of...
This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...
This federal contract award is for the provision of 2 Oncotype DX Pathology Tests by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract was awarded by the Air Education and Training Command, a defense agency, and has a ceiling value of $6,907.92. It is a firm fixed-price delivery order contract under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does not have a set-aside designation. Genomic Health, Inc. is the...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide laboratory testing services. The contract has a potential value of $165,621.24 and a period of performance through September 30, 2020. Genomic Health has previously provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under over 30...
This is a $6,907.92 firm fixed-price purchase order awarded by the U.S. Air Education and Training Command to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Oncotype Pathology Test services, which are advanced genetic testing services used to support cancer screening, treatment selection, and disease monitoring. Genomic Health, Inc. is an experienced federal contractor, having previously secured multiple Indefinite Delivery Vehicles...
This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...